[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Neurostimulation Device Market Size study, by Device Type (Spinal Cord Stimulators, Deep Brain Stimulators, Sacral Nerve Stimulators, Vagus Nerve Stimulators, Others), by Application (Pain Management, Hearing Loss, Urinary Incontinence, Parkinson's Disease, Epilepsy, Others) and Regional Forecasts 2020-2027

July 2020 | 200 pages | ID: G5D41505B258EN
Bizwit Research & Consulting LLP

US$ 4,950.00

E-mail Delivery (PDF), Hard Copy Mail Delivery

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
Global Neurostimulation Device Market is valued at approximately USD 4.8 billion in 2019 and is anticipated to grow with a healthy growth rate of more than 12.5% over the forecast period 2020-2027. Neurostimulation devices are surgically implanted devices used in the patient and functioning through thin wires or leads. They are an effective therapeutic solution for pain management on numerous medical conditions, such as diabetic neuropathy or failed back surgery. These devices often help in the electrical stimulation delivered to the intended parts of the patient’s brain, spinal cord, and peripheral nervous system. These devices deliberately carried out via using invasive and non-invasive procedures. Recently, the global burden of the COVID-19 pandemic has led to a rise in demand for neurostimulation devices and other essential medical supplies in identifying or monitoring and diagnosis of the patient's medical condition to prevent or mitigate the risk of a novel coronavirus, as well as provide optimum care to the patient. This is likely to promote market growth all over the world. Furthermore, these devices are specifically used for the treatment of various diseases, including epilepsy, Parkinson’s disease, chronic pain, and depression. Therefore, the increasing prevalence of diseases, particularly Parkinson's and epilepsy with a growing geriatric population, and the introduction of technologically advanced neurostimulators are few other factors responsible for the market growth over the forecast period. According to the study of Global Burden of Disease 2015, the global prevalence of Parkinson’s diseases to be approximately 6.2 million people and it would reach almost 13 million people with Parkinson’s by 2040. Also, the Parkinson’s Disease Foundation revealed that nearly 60,000 Americans are diagnosed with Parkinson’s disease every year. This, in turn, is projected to leverage the demand for neurostimulation devices across the globe. However, the presence of strict regulatory guidelines for product-approval and adverse effects and risks related to neurostimulation devices are the major factors impeding the market growth over the forecast period of 2020-2027.

The regional analysis of the global Neurostimulation Device market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to the increasing prevalence of neurological disorder, along with the presence of new technology-based solution providers in the region. Whereas, Asia-Pacific is anticipated to exhibit the highest growth rate / CAGR over the forecast period 2020-2027. Factors such as the presence of unmet medical needs and the rising incidence of osteoporosis and neurological disorder would create lucrative growth prospects for the Neurostimulation Device market across the Asia-Pacific region.

Major market player included in this report are:
Abbott Laboratories
Aleva Neurotherapeutics SA
Boston scientific corporation
ElectroCore Inc.
EndoStim Inc.
Medtronic plc
NeuroPace Inc.
Nevro Corporation
Neuronetics Inc.
Synapse Biomedical Inc.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Device Type:
Spinal Cord Stimulators
Deep Brain Stimulators
Sacral Nerve Stimulators
Vagus Nerve Stimulators
Others

By Application:
Pain Management
Hearing Loss
Urinary Incontinence
Parkinson's Disease
Epilepsy
Others

By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2017, 2018
Base year – 2019
Forecast period – 2020 to 2027

Target Audience of the Global Neurostimulation Device Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
CHAPTER 1. EXECUTIVE SUMMARY

1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2018-2027 (USD Billion)
  1.2.1. Neurostimulation Device Market, by Region, 2018-2027 (USD Billion)
  1.2.2. Neurostimulation Device Market, by Device Type, 2018-2027 (USD Billion)
  1.2.3. Neurostimulation Device Market, by Application, 2018-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption

CHAPTER 2. GLOBAL NEUROSTIMULATION DEVICE MARKET DEFINITION AND SCOPE

2.1. Objective of the Study
2.2. Market Definition & Scope
  2.2.1. Scope of the Study
  2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates

CHAPTER 3. GLOBAL NEUROSTIMULATION DEVICE MARKET DYNAMICS

3.1. Neurostimulation Device Market Impact Analysis (2018-2027)
  3.1.1. Market Drivers
  3.1.2. Market Challenges
  3.1.3. Market Opportunities

CHAPTER 4. GLOBAL NEUROSTIMULATION DEVICE MARKET INDUSTRY ANALYSIS

4.1. Porter’s 5 Force Model
  4.1.1. Bargaining Power of Suppliers
  4.1.2. Bargaining Power of Buyers
  4.1.3. Threat of New Entrants
  4.1.4. Threat of Substitutes
  4.1.5. Competitive Rivalry
  4.1.6. Futuristic Approach to Porter’s 5 Force Model (2017-2027)
4.2. PEST Analysis
  4.2.1. Political
  4.2.2. Economical
  4.2.3. Social
  4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion

CHAPTER 5. GLOBAL NEUROSTIMULATION DEVICE MARKET, BY DEVICE TYPE

5.1. Market Snapshot
5.2. Global Neurostimulation Device Market by Device Type, Performance - Potential Analysis
5.3. Global Neurostimulation Device Market Estimates & Forecasts by Device Type 2017-2027 (USD Billion)
5.4. Neurostimulation Device Market, Sub Segment Analysis
  5.4.1. Spinal Cord Stimulators
  5.4.2. Deep Brain Stimulators
  5.4.3. Sacral Nerve Stimulators
  5.4.4. Vagus Nerve Stimulators
  5.4.5. Others

CHAPTER 6. GLOBAL NEUROSTIMULATION DEVICE MARKET, BY APPLICATION

6.1. Market Snapshot
6.2. Global Neurostimulation Device Market by Application, Performance - Potential Analysis
6.3. Global Neurostimulation Device Market Estimates & Forecasts by Application 2017-2027 (USD Billion)
6.4. Neurostimulation Device Market, Sub Segment Analysis
  6.4.1. Pain Management
  6.4.2. Hearing Loss
  6.4.3. Urinary Incontinence
  6.4.4. Parkinson's Disease
  6.4.5. Epilepsy
  6.4.6. Others

CHAPTER 7. GLOBAL NEUROSTIMULATION DEVICE MARKET, REGIONAL ANALYSIS

7.1. Neurostimulation Device Market, Regional Market Snapshot
7.2. North America Neurostimulation Device Market
  7.2.1. U.S. Neurostimulation Device Market
    7.2.1.1. Device Type breakdown estimates & forecasts, 2017-2027
    7.2.1.2. Application breakdown estimates & forecasts, 2017-2027
  7.2.2. Canada Neurostimulation Device Market
7.3. Europe Neurostimulation Device Market Snapshot
  7.3.1. U.K. Neurostimulation Device Market
  7.3.2. Germany Neurostimulation Device Market
  7.3.3. France Neurostimulation Device Market
  7.3.4. Spain Neurostimulation Device Market
  7.3.5. Italy Neurostimulation Device Market
  7.3.6. Rest of Europe Neurostimulation Device Market
7.4. Asia-Pacific Neurostimulation Device Market Snapshot
  7.4.1. China Neurostimulation Device Market
  7.4.2. India Neurostimulation Device Market
  7.4.3. Japan Neurostimulation Device Market
  7.4.4. Australia Neurostimulation Device Market
  7.4.5. South Korea Neurostimulation Device Market
  7.4.6. Rest of Asia Pacific Neurostimulation Device Market
7.5. Latin America Neurostimulation Device Market Snapshot
  7.5.1. Brazil Neurostimulation Device Market
  7.5.2. Mexico Neurostimulation Device Market
7.6. Rest of The World Neurostimulation Device Market

CHAPTER 8. COMPETITIVE INTELLIGENCE

8.1. Top Market Strategies
8.2. Company Profiles
  8.2.1. Abbott Laboratories
    8.2.1.1. Key Information
    8.2.1.2. Overview
    8.2.1.3. Financial (Subject to Data Availability)
    8.2.1.4. Product Summary
    8.2.1.5. Recent Developments
  8.2.2. Aleva Neurotherapeutics SA
  8.2.3. Boston scientific corporation
  8.2.4. ElectroCore Inc.
  8.2.5. EndoStim Inc.
  8.2.6. Medtronic plc
  8.2.7. NeuroPace Inc.
  8.2.8. Nevro Corporation
  8.2.9. Neuronetics Inc.
  8.2.10. Synapse Biomedical Inc.

CHAPTER 9. RESEARCH PROCESS

9.1. Research Process
  9.1.1. Data Mining
  9.1.2. Analysis
  9.1.3. Market Estimation
  9.1.4. Validation
  9.1.5. Publishing
9.2. Research Attributes
9.3. Research Assumption

LIST OF TABLES

TABLE 1. Global Neurostimulation Device market, report scope
TABLE 2. Global Neurostimulation Device market estimates & forecasts by region 2017-2027 (USD Billion)
TABLE 3. Global Neurostimulation Device market estimates & forecasts by Device Type 2017-2027 (USD Billion)
TABLE 4. Global Neurostimulation Device market estimates & forecasts by Application 2017-2027 (USD Billion)
TABLE 5. Global Neurostimulation Device market by segment, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 6. Global Neurostimulation Device market by region, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 7. Global Neurostimulation Device market by segment, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 8. Global Neurostimulation Device market by region, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 9. Global Neurostimulation Device market by segment, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 10. Global Neurostimulation Device market by region, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 11. Global Neurostimulation Device market by segment, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 12. Global Neurostimulation Device market by region, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 13. Global Neurostimulation Device market by segment, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 14. Global Neurostimulation Device market by region, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 15. Global Neurostimulation Device market by segment, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 16. Global Neurostimulation Device market by region, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 17. Global Neurostimulation Device market by segment, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 18. Global Neurostimulation Device market by region, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 19. Global Neurostimulation Device market by segment, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 20. Global Neurostimulation Device market by region, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 21. U.S. Neurostimulation Device market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 22. U.S. Neurostimulation Device market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 23. U.S. Neurostimulation Device market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 24. Canada Neurostimulation Device market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 25. Canada Neurostimulation Device market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 26. Canada Neurostimulation Device market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 27. UK Neurostimulation Device market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 28. UK Neurostimulation Device market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 29. UK Neurostimulation Device market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 30. Germany Neurostimulation Device market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 31. Germany Neurostimulation Device market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 32. Germany Neurostimulation Device market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 33. France Neurostimulation Device market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 34. France Neurostimulation Device market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 35. France Neurostimulation Device market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 36. Spain Neurostimulation Device market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 37. Spain Neurostimulation Device market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 38. Spain Neurostimulation Device market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 39. Italy Neurostimulation Device market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 40. Italy Neurostimulation Device market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 41. Italy Neurostimulation Device market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 42. ROE Neurostimulation Device market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 43. ROE Neurostimulation Device market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 44. ROE Neurostimulation Device market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 45. China Neurostimulation Device market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 46. China Neurostimulation Device market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 47. China Neurostimulation Device market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 48. India Neurostimulation Device market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 49. India Neurostimulation Device market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 50. India Neurostimulation Device market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 51. Japan Neurostimulation Device market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 52. Japan Neurostimulation Device market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 53. Japan Neurostimulation Device market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 54. Australia Neurostimulation Device market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 55. Australia Neurostimulation Device market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 56. Australia Neurostimulation Device market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 57. South Korea Neurostimulation Device market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 58. South Korea Neurostimulation Device market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 59. South Korea Neurostimulation Device market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 60. ROPAC Neurostimulation Device market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 61. ROPAC Neurostimulation Device market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 62. ROPAC Neurostimulation Device market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 63. Brazil Neurostimulation Device market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 64. Brazil Neurostimulation Device market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 65. Brazil Neurostimulation Device market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 66. Mexico Neurostimulation Device market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 67. Mexico Neurostimulation Device market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 68. Mexico Neurostimulation Device market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 69. ROLA Neurostimulation Device market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 70. ROLA Neurostimulation Device market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 71. ROLA Neurostimulation Device market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 72. ROW Neurostimulation Device market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 73. ROW Neurostimulation Device market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 74. ROW Neurostimulation Device market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 75. List of secondary sources, used in the study of global Neurostimulation Device market
TABLE 76. List of primary sources, used in the study of global Neurostimulation Device market
TABLE 77. Years considered for the study
TABLE 78. Exchange rates considered

LIST OF FIGURES

FIG 1. Global Neurostimulation Device market, research methodology
FIG 2. Global Neurostimulation Device market, market estimation techniques
FIG 3. Global market size estimates & forecast methods
FIG 4. Global Neurostimulation Device market, key trends 2019
FIG 5. Global Neurostimulation Device market, growth prospects 2020-2027
FIG 6. Global Neurostimulation Device market, porters 5 force model
FIG 7. Global Neurostimulation Device market, pest analysis
FIG 8. Global Neurostimulation Device market, value chain analysis
FIG 9. Global Neurostimulation Device market by segment, 2017 & 2027 (USD Billion)
FIG 10. Global Neurostimulation Device market by segment, 2017 & 2027 (USD Billion)
FIG 11. Global Neurostimulation Device market by segment, 2017 & 2027 (USD Billion)
FIG 12. Global Neurostimulation Device market by segment, 2017 & 2027 (USD Billion)
FIG 13. Global Neurostimulation Device market by segment, 2017 & 2027 (USD Billion)
FIG 14. Global Neurostimulation Device market by segment, 2017 & 2027 (USD Billion)
FIG 15. Global Neurostimulation Device market by segment, 2017 & 2027 (USD Billion)
FIG 16. Global Neurostimulation Device market by segment, 2017 & 2027 (USD Billion)

COMPANIES MENTIONED

Abbott Laboratories
Aleva Neurotherapeutics SA
Boston scientific corporation
ElectroCore Inc.
EndoStim Inc.
Medtronic plc
NeuroPace Inc.
Nevro Corporation
Neuronetics Inc.
Synapse Biomedical Inc.


More Publications